Intracranial neoplasms

Known intracranial neoplasm lants in therapeutics doses... 

Known arteriovenous malformation, aneurysm, or intracranial neoplasm... 

Intracranial neoplasm, mass lesion, or evidence of cerebral herniation... 

Absolute contraindications to fibrinolytic therapy include (1) active internal bleeding (2) previous ICH at anytime (3) ischemic stroke within 3 months (4) known intracranial neoplasm (5) known structural vascular lesion (6) suspected aortic dissection and (7) significant closed head or facial trauma within 3 months. Primary PCI is preferred in these situations. 

Contraindications Active internal bleeding, arteriovenous malformation or aneurysm, cerebrovascular accident (CVA) with residual neurologic defect, history of CVA (within the past 2 yr) or oral anticoagulant use within the past 7 days unless PT is less than 1.2 X control, history of vasculitis, hypersensitivity to murine proteins, intracranial neoplasm, prior IV dextran use before or during percutaneous transluminal coronary angioplasty (PTCA), recent surgery or trauma (within the past 6 wk), recent (within the past 6 wk or less) GI or GU bleeding, thrombocytopenia (less than 100,000 cells/pl), and severe uncontrolled hypertension... 

Contraindications Active internal bleeding, AV malformation or aneurysm, bleeding diathesis, intracranial neoplasm, intracranial orintraspinal surgery or trauma, recent (within past 2 mo) cerebrovascular accident, severe uncontrolled hypertension... 

Contraindications Active internal bleeding, evidence of cerebral herniation, intracranial neoplasm or mass lesion, presence of an epidural catheter, recent (within the past 3 mo) hemorrhagic stroke, recent (within the past 2 mo) intracranial or intraspinal surgery or severe head trauma, trauma with an increased risk of life-threatening bleeding... 

Contraindications Active internal bleeding or a history of bleeding diathesis within previous 30 days, arteriovenous malformation or aneurysm, history of intracranial hemorrhage, history of thrombocytopenia after prior exposure to tirofiban, intracranial neoplasm, major surgical procedure within previous 30 days, severe hypertension, stroke... 

Williams, P.C., et al. 1995. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery 37 17. 

Active internal bleeding, history of CVA, recent intracranial or intraspinal surgery or trauma, intracranial neoplasm, arteriovenous malformation or aneurysm, bleeding diathesis or severe uncontrolled hypertension (increases risk of bleeding)... 

Wilkins JR III, McLaughlin JA, Sinks TH, et al. Parental occupation and intracranial neoplasms of childhood Anecdotal evidence from a unique occupational cancer cluster. J Am IndMed 1991 19 643 53. 

A unique cancer cluster was reported in which children of parents (both mothers or fathers) who worked at the same electronics manufacturing plant developed intracranial neoplasms.I12 Parents were exposed to some 30 different chemical classes containing more than 100 different compounds. These compounds included... 

Meningeal location is a major discriminator of meningioma from other primary intracranial neoplasms (Table 20.9 see Tables 20.5 to 20.7). Meningiomas are attached to dura or falx, which facilitates their recognition. Meningiomas arise less commonly from the choroid plexus and rarely within the CNS parenchyma. 

T.C. Origitano, M.J. Caron, O.H. Reichman (1994). Photodynamic therapy for intracranial neoplasms. Literature review and institutional experience. Mol. Chem. NeuropathoL, 21(2-3), 337-352. 

Qureshi, A.I. (2004) Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet, 363 804-813. 

Mealey, J., Brownell, G. L., and Sweet, W. H., 1959, Radloarsenlc in plasma, urine, normal tissues and Intracranial neoplasms. Arch. Neurol. Psychlat., 81 310-320. 

---